The Wainright Protocol: A Legacy Rooted in Fermented Soy Therapy

Walter H. Wainright, founder of U.S. Research, became one of its most vocal and persistent advocates of the nitrogen fermented soy beverage Haelan 951. A passionate researcher and pioneer in nutritional oncology, Wainright devoted decades to studying the mechanisms and clinical applications of this unique formulation. He helped establish what some call the "Wainright Protocol"—a nutritionally-focused approach centered on nitrogen-fermented soy designed to support the body through the challenges of cancer and protein-calorie malnutrition.

The Wainright Protocol At the heart of the Wainright Protocol is the daily consumption of 8 ounces of Haelan 951, typically administered in two 4-ounce servings per day for 60 to 90 days. Haelan 951 is a fermented soy beverage created through a nitrogen-assisted fermentation process that enhances the bioavailability of isoflavones and preserves critical phytonutrients. nitrogenated soy is a breakthrough in the nutritional value of fermented soy. Learn more about that here.

Patients are advised to consume Haelan 951 on an empty stomach and avoid substances that interfere with nutrient uptake—like refined sugars, caffeine, or alcohol. The goal of the protocol is multi-pronged: reduce inflammation, support immune surveillance, promote cancer cell differentiation, suppress tumor growth, and reverse cachexia.

Scientific Foundation and Mechanisms of Action Wainright’s advocacy is supported by a broad range of preclinical and clinical studies that illuminate the biological mechanisms behind Haelan 951’s effectiveness. These include:

• Isoflavone Activity (Genistein and Daidzein): These compounds inhibit cancer proliferation by targeting the Notch-1 and NF-κB pathways. Genistein has been shown to reduce tumor viability in triple-negative breast cancer (TNBC) by inducing G2/M cell cycle arrest and apoptosis.
• Calpain Inhibition Synergy: In pancreatic cancer cell lines, Haelan 951 reduced proliferation and induced apoptosis. When paired with calpain inhibitors, these effects were enhanced—suggesting synergy with other anti-cancer agents that influence apoptotic pathways.
• Hormone Modulation and Tumor Suppressor Gene Activation: Studies have found that Haelan 951 increases the expression of tumor suppressor genes such as TP53 and p21, and enhances the differentiation of circulating tumor cells (CTCs). This is especially relevant in hormone-independent and treatment-resistant cancers.
• Reduction in Inflammatory Cytokines: Haelan 951 downregulates pro-inflammatory cytokines such as TNF-α and IL-6. This leads to suppression of NF-κB activity, a key driver of tumor progression, immune dysfunction, and cachexia.
• Improved Hematologic Profiles: In clinical settings, Haelan 951 helped stabilize white blood cell counts during chemotherapy, decreased the need for blood transfusions, and reduced leukocytopenia and thrombocytopenia.
• Cachexia and Nutritional Reversal: Multiple studies report significant reversal of cancer-related cachexia in patients receiving Haelan 951. Appetite returned, weight loss stabilized, and energy levels improved—making patients more resilient through conventional treatments.

Expanded Potential Uses While most attention has focused on Haelan 951’s use in oncology, its broad systemic effects suggest wider applications:

• Adjunct to Chemotherapy and Radiation: Reduces side effects and may help resensitize tumors that have developed treatment resistance.
• Autoimmune Conditions and Chronic Inflammation: Through its modulation of cytokine and NF-κB signaling, Haelan may benefit autoimmune and inflammatory disorders.
• Viral Defense and Immune Restoration: Given its effects on white blood cell activity and cytokine profiles, it may serve as an immune-recovery agent in chronic viral conditions.
• Gut-Brain Axis and Neuroinflammation: Preliminary observations suggest that by reducing systemic inflammation and supporting gut health, Haelan 951 may positively influence mood, fatigue, and cognitive symptoms in chronic illness.

Clinical Success Stories and Testimonials The Wainright Protocol has been embraced by patients seeking alternatives or complements to conventional therapy. Testimonials underscore the product's transformative potential:

Sherry Morrison – Stage IV Breast Cancer

Sherry Morrison from Atlanta, Georgia was diagnosed with Stage IV breast cancer, a metastatic and typically terminal condition. Opting out of conventional chemotherapy, she turned to Haelan 951 as her primary intervention, consuming one full 8-ounce bottle daily. Over a ten-month period, her PET scans showed progressive improvement, eventually revealing no active cancerous lesions. Sherry credits her remission largely to the Haelan 951 protocol, reporting minimal side effects and vastly improved energy and vitality throughout her journey.

Robert Mitchell – Stage III Colon Cancer

Diagnosed with Stage III colon cancer in 2007, Robert Mitchell of San Antonio faced complications that prevented him from undergoing chemotherapy. Instead, he committed to a nutritional regimen built around the Wainwright Protocol, drinking 4 ounces of Haelan 951 in the morning and another 4 ounces at night for nearly a year. Regular scans confirmed that the cancer did not return, and Robert remains in remission. His success stands as a testament to the potential of fermented soy as a standalone therapeutic aid when conventional treatment isn’t an option.

Platinum-Resistant Ovarian Cancer Patient – Massachusetts General Hospital

A 56-year-old woman with rapidly progressing, platinum-resistant ovarian cancer turned to Haelan 951 after exhausting conventional treatment options, including multiple rounds of chemotherapy and a failed clinical trial. Beginning with a self-directed regimen of 4 ounces per day, she soon experienced a dramatic reduction in symptoms and stabilization of her disease. Notably, her CA-125 tumor marker dropped significantly, and CT scans showed no further progression. Her case was published in Gynecologic Oncology, lending rare academic visibility to the impact of this fermented soy beverage in advanced gynecologic cancers.

Bobby – Prostate Cancer

Bobby, a man with a significant familial risk for prostate cancer, received his own diagnosis after elevated PSA levels and concerning vascular imaging. Determined to avoid the same fate as his father, he began taking one bottle of Haelan 951 daily. Within six months, his PSA levels had normalized, and his vascularity index returned to healthy levels—surprising his physicians, who were unaware he had been following the Wainwright Protocol. Bobby’s proactive approach may have saved him from invasive treatment and long-term hormonal therapy.

Joy Lofquist – Crohn’s Disease and Cancer Risk

Suffering from Crohn’s Disease since the early 1980s, Joy Lofquist had endured decades of inflammation, compromised immunity, and concerns about colorectal cancer risk. After discovering Haelan 951, she gradually phased out her immunosuppressive medications and chemotherapy pills. Roughly 8–10 months later, a colonoscopy revealed no trace of the disease’s previous markers. More than ten years have passed since her remission, and Joy remains symptom-free, citing Haelan 951 as the cornerstone of her long-term healing.

Laura – Ovarian and Uterine Cancer

In 2013, Laura was diagnosed with dual gynecologic cancers: Stage II ovarian and Stage I uterine. Rather than pursue traditional chemotherapy, she followed a strict regimen of Haelan 951, consuming 4 ounces in the morning and another 4 ounces in the evening. Within just eight weeks after surgery, her CA-125 levels dropped from 150 to 33, an impressive shift that surprised her doctors. Laura continued the regimen for almost a year and remains cancer-free, using Haelan 951 for maintenance and prevention.

Sherman Sanders – Cholangiocarcinoma (Liver Cancer)

Sherman Sanders was diagnosed with cholangiocarcinoma, a rare and aggressive form of liver cancer with a typically poor prognosis. Following the standard prognosis of limited options and a grim outlook, Sherman embraced the Wainwright Protocol, taking a full bottle of Haelan 951 daily for four months. Remarkably, he achieved remission and remained cancer-free for more than six years afterward, defying statistical expectations and giving hope to others with similarly challenging diagnoses.

Anonymous – Stage IV Lung Cancer

A man diagnosed with Stage IV lung cancer that had metastasized to the brain opted for Haelan 951 after conventional treatments failed to halt the disease’s progression. He took 8 ounces daily alongside lifestyle changes and an anti-inflammatory diet. Over time, imaging revealed not only stabilization of his cancer, but also tumor shrinkage. He credited Haelan 951 with boosting his immunity, restoring his strength, and allowing his body to mount a more effective defense against the disease.

“Bradley” the Shetland Sheepdog – Prostate Cancer in Pets

Bradley, a beloved Shetland sheepdog, was diagnosed with prostate cancer—a terminal condition in canines. His owners administered 2 ounces of Haelan 951 twice daily, hoping to improve his quality of life. Within weeks, Bradley exhibited renewed energy, a shiny and thickened coat, and a marked return to his old, playful demeanor. Though his disease was not cured, the treatment extended his life and vastly improved his well-being in his final months. His case suggests broader applications for Haelan 951 in veterinary care.

Julie – Stage IV Melanoma

Julie was diagnosed with metastatic melanoma that had spread to multiple organs. As an alternative approach, she integrated Haelan 951 into her regimen, alongside a clean, anti-inflammatory diet. She took the supplement faithfully over several months. Follow-up scans revealed tumor shrinkage and reduced inflammation. More importantly, Julie reported a complete turnaround in energy, focus, and quality of life, crediting Haelan 951 with helping her body fight back where conventional therapies had failed.

The Mysterious Death of Walter Wainright Despite his contributions to integrative oncology, Walter Wainright’s death is surrounded by mystery. Public records offer few details, and his passing was not widely reported. This led to speculation among supporters that his work—and the threat it posed to conventional cancer treatment markets—may have contributed to a deliberate marginalization.

Conclusion: The Enduring Impact of the Wainright Protocol The Wainright Protocol is more than a nutritional regimen; it is a philosophy of care that prioritizes cellular integrity, immune balance, and the body’s intrinsic healing intelligence. Wainright’s vision of a low-toxicity, high-impact nutritional therapy for cancer remains relevant today, especially as the limitations of monotherapeutic drug approaches become increasingly evident.

Although more large-scale clinical trials are warranted, the accumulated evidence and real-world testimonials position Haelan 951—and the Wainright Protocol—as a compelling candidate for integration into modern oncologic and chronic care strategies.

Haelan 951 is still made available at www.haelan951.com 800-542-3526

To learn more about the specifics of the studies that lead Walter Wainright to these conclusions, please see the research section.